Biphenyl-4-carboxamide - CAS 3815-20-1
Catalog: |
BB023551 |
Product Name: |
Biphenyl-4-carboxamide |
CAS: |
3815-20-1 |
Synonyms: |
4-phenylbenzamide |
IUPAC Name: | 4-phenylbenzamide |
Description: | Biphenyl-4-carboxamide (CAS# 3815-20-1) is a useful research chemical. |
Molecular Weight: | 197.23 |
Molecular Formula: | C13H11NO |
Canonical SMILES: | C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)N |
InChI: | InChI=1S/C13H11NO/c14-13(15)12-8-6-11(7-9-12)10-4-2-1-3-5-10/h1-9H,(H2,14,15) |
InChI Key: | LUQVCHRDAGWYMG-UHFFFAOYSA-N |
Boiling Point: | 381.4 °C at 760 mmHg |
Melting Point: | 227-229 °C |
Purity: | 98 % |
Density: | 1.137 g/cm3 |
Appearance: | Cream colored powder |
MDL: | MFCD00017573 |
LogP: | 3.15280 |
GHS Hazard Statement: | H302 (90.48%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P280, P301+P312, P305+P351+P338, P330, P337+P313, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021203055-A1 | Viral entry inhibitors and rna polymerase inhibitors | 20200403 |
WO-2021202694-A1 | Phenolic acid lipid based cationic lipids | 20200401 |
CN-113462278-A | Varnish composition, method for producing polyimide resin, and additive | 20200331 |
WO-2021195401-A1 | Technologies for preventing or treating infections | 20200325 |
WO-2021195024-A1 | Adjuvant compounds, salt forms, and formulations | 20200323 |
PMID | Publication Date | Title | Journal |
18602269 | 20081201 | Synthesis of new carbon-11-labeled carboxamide derivatives as potential PET dopamine D3 receptor radioligands | Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine |
16289819 | 20060215 | 6-Acylamino-2-amino-4-methylquinolines as potent melanin-concentrating hormone 1 receptor antagonists: structure-activity exploration of eastern and western parts | Bioorganic & medicinal chemistry letters |
11888550 | 20020401 | Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization | Pharmacology, biochemistry, and behavior |
Complexity: | 213 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 197.084063974 |
Formal Charge: | 0 |
Heavy Atom Count: | 15 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 197.084063974 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 43.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.9 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS